- Home
- IPA vs SHFS Comparison
IPA vs SHFS Comparison
Compare IPA & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- SHFS
- Stock Information
- Founded
- IPA 1983
- SHFS 2015
- Country
- IPA United States
- SHFS United States
- Employees
- IPA N/A
- SHFS N/A
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- SHFS Finance: Consumer Services
- Sector
- IPA Health Care
- SHFS Finance
- Exchange
- IPA Nasdaq
- SHFS Nasdaq
- Market Cap
- IPA 22.4M
- SHFS 20.8M
- IPO Year
- IPA 2017
- SHFS N/A
- Fundamental
- Price
- IPA $0.70
- SHFS $2.30
- Analyst Decision
- IPA Strong Buy
- SHFS
- Analyst Count
- IPA 2
- SHFS 0
- Target Price
- IPA $4.00
- SHFS N/A
- AVG Volume (30 Days)
- IPA 524.9K
- SHFS 19.8K
- Earning Date
- IPA 07-28-2025
- SHFS 05-21-2025
- Dividend Yield
- IPA N/A
- SHFS N/A
- EPS Growth
- IPA N/A
- SHFS N/A
- EPS
- IPA N/A
- SHFS N/A
- Revenue
- IPA $16,581,105.00
- SHFS $13,956,453.00
- Revenue This Year
- IPA $4.67
- SHFS N/A
- Revenue Next Year
- IPA $14.15
- SHFS N/A
- P/E Ratio
- IPA N/A
- SHFS N/A
- Revenue Growth
- IPA 1.34
- SHFS N/A
- 52 Week Low
- IPA $0.27
- SHFS $1.84
- 52 Week High
- IPA $1.08
- SHFS $14.86
- Technical
- Relative Strength Index (RSI)
- IPA 81.29
- SHFS 40.20
- Support Level
- IPA $0.50
- SHFS $2.25
- Resistance Level
- IPA $0.58
- SHFS $2.80
- Average True Range (ATR)
- IPA 0.05
- SHFS 0.25
- MACD
- IPA 0.01
- SHFS 0.06
- Stochastic Oscillator
- IPA 83.10
- SHFS 43.01
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.